Nebivolol contraindications: Difference between revisions

Latest revision as of 01:30, 22 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Nebivolol#Contraindications]]
-{{Nebivolol}}
-{{CMG}}; {{AE}} {{SS}}
-====
-BYSTOLIC is contraindicated in the following conditions:
-*Severe [[bradycardia]]
-*Heart block greater than first degree
-*Patients with cardiogenic shock
-*Decompensated [[cardiac failure]]
-*Sick sinus syndrome (unless a permanent pacemaker is in place)
-*Patients with severe hepatic impairment (Child-Pugh >B)
-*Patients who are hypersensitive to any component of this product.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = BYSTOLIC (NEBIVOLOL HYDROCHLORIDE) TABLET [FOREST LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b8ad213-1dc8-454e-a524-075685c0e1a8 | publisher =  | date =  | accessdate = 4 February 2014 }}</ref>
-==References==
-{{Reflist|2}}
-[[Category:Beta blockers]]
-[[Category:Cardiovascular Drugs]]
-[[Category:Drugs]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}